The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
They issued too much stock and too many warrants.
One of the biggest roadblocks for lab grown meat, the cost of pharma grade growth medium, might be solved.
https://www.reuters.com/article/israel-startup-lab-meat/tobacco-has-new-role-to-play-in-cultivated-meat-production-israeli-biotech-says-idUSL5N2VW2GG
As good value as SBTX before you lost 50% on it when it was definitely going to a quid?
Maybe invest your fiver elsewhere lol.
Because some shareholders care if the shares are short-mid term good value.
Question is if the market will try to price shares in cultured meat the same way. I hope not, but it is part of a wider trend of valuing growth/tech stocks more less speculatively.
I've thought about that too. I think the distinction is that there will always be a decent market segment that don't want the unnatural ingredients in their food that plant-based meats have. They're often quite calorific, filled with things like coconut oil, emulsifiers, colorants and the like. There are exceptions to this, like quorn, though the taste still differs a lot from meat and it's just sold under the quorn name brand as far as I know.
If cultured meat reaches technological goals, it'll be produced at scale and sold under many brand names. It'll be the only way to eat certain meats and fish which just aren't available - mahi mahi fish, zebra, whatever. Certain seafood and meat products are much more expensive due to scarcity, but that wouldn't be an issue for cultured meat so long as capital investment is high enough to produce at scale. It'll make it easier to produce products on site without the need for cross continental transport or dependency on foreign nations. Unlike plant based meats, processed cultured meat could make it's way into existing meat products to drive down costs, and so it may not feature heavily on the packaging that it is cultured meat.
I'm sure there's a lot you're not happy with. Try taking a break from the computer.
I bought most of my shares in HE1 at 7p so my return was still decent. It has nothing to do with Agronomics though.
Thanks MAZ, I'd much rather hear the bear case to help guide the discussion rather than be stuck in an echo chamber and only read 'positive' comments.
The beginning of the article (https://thecounter.org/lab-grown-cultivated-meat-cost-at-scale/) completely plays down that the cost of producing lab grown meat has dropped by orders of magnitude in the last decade and is continuing to do so. Instead, the author states that the price of production is high, as if statically high.
"Most of us have a limited appetite for 50-dollar lab-grown chicken nuggets."
The article references a study by Humbird (https://onlinelibrary.wiley.com/doi/full/10.1002/bit.27848) based on current costs, especially the costs of amino acids, which are currently produced in small amounts for the pharmaceutical industry. It projects that on a relatively small scale that the costs of production of raw materials would still be prohibitively high.
Unfortunately, as it stands, we have no idea exactly what materials will be used in a few more years for lab grown meat. There are many candidates for driving down the cost of the medium used in cultured meat. This video has a good section on candidates. (https://youtu.be/fMw0aL_7leE?t=1154) I think it's disingenuous to say that the costs of raw materials produced are too high for large scale production when the situation is constantly evolving, and now that there is finally funding being put to work on this.
Though I did like that the author said that it would take several thousand such large facilities to meet the world's total meat supply. Assuming that alternatives to current raw materials are developed, all his calculations would amount to is the world's meat demand being provided more cheaply by just a few thousand factories! haha
I'm finding these presentations very informative.
https://2020.cmsymp.com/attend/
Which company do you lot think is closest to large scale production?
The price dropping on significant shows with 2 more drill locations to go :O BUY
Thanks Olderandwiser! It is tricky enough combing through different investment opportunities and get one's head around them without being attacked for no good reason. Thanks for the other helpful responses - they were helpful although I'll still give it time before possibly taking a position. Now to put aside etiquette.
Phat and TedJames, I'm sorry that I haven't reached your dizzying heights of wisdom. I had a look through your posts to learn from your past investments.
TedJames, I wasn't there when you posted crying about losing all your money when you thought you were going to become a millionaire in 2019:
'Oh, why didn't I cash out? Greedy! I remember one shareholder proclaimed he had become a millionaire and we started a millionaire group. Now he's probably back to £100K (If that) As is stands I'm a long term holder, that's what I keep telling myself. How long, is long?'
Or when you lost it all on NEW when it folded...
'Okay so just signed up so I could make a comment, what the hell is going on! I was £500 in, and then they said buy more shares and now I'm £5k in and currently! Am I right to think I'll never see a penny again? Has anyone made a complaint or contact FSO? Or is it live by the sword and die by the sword.'
And Phat, your posts are a litany of failed price predictions and name calling. It's kind of astounding that you would be the judge of a successful investor when almost every stock you pump seems to be less than half the value even years later...
After learning from your past investments, I decided to join a millionaire's group on Facebook and pump stocks by giving 100-500% price targets. Thank you both.
I'm still not seeing anybody answer any of the points I raised.
It's one thing to be bullish on a stock but it's entirely another to try to exist inside an echo chamber and screech insults at anyone asking real questions.
Remember, this is a biotech stock. Any 'successful investor' would do research and get a good grasp of the product which is being discussed. If you can't answer any enquiry seriously, you can laugh all you like, you won't be making any money my friend.
And no, it would have been 2000-5000. Not a large investment, but not five pounds. Thanks for your nonsensical insults.
Thanks for the reasonable response Aquae. It's helpful to find out why other investors have chosen to invest.
Mathurin, I'd like to invest but in my eyes there's not sufficient information to make an investment decision.
A) I still haven't found out the bacterial strains used in the probiotic product which I would expect would have to be printed on the box for consumers regardless. There aren't any probiotic products out there that don't state the bacterial strains on the back, nor any that don't explain to consumers clearly how their product works.
B) The patents I looked through related to filtered probiotic bacteria lysates for use on the skin/skin repair. There is a patent on a probiotic extract comprising of a protein fraction which could bear relation to the ingestible product.
C) The FAQ states that a patent has been filed. Filing a patent and having a patent granted isn't the same thing.
D) I can see that investors here are using the defer to authority argument to support an investment decision. That is, the founders are credible scientists in the relevant field of study so the products must be equally credible. That is fine if there is also a lot of supporting evidence (i.e. the founder publishing an academic study on their work) but there's nothing I can find except some pictures handpicked by the company in their results.
That doesn't mean I won't ever invest but I require more information - and probably a granted patent on the flagship product - to balance out the risk/reward ratio in my mind.
Nope, I'm genuinely asking because I was thinking of investing.
Who **** in your cornflakes?
Probably going to get a lot of hate but I still can't find any solid information on the science behind the supplement. Presentations gloss over it and there's nothing in the results. Patents also don't seem to relate to 6 live bacterial strains but more to the bacterial extracts and lysates as they apply to the cosmetic side of the business.
https://worldwide.espacenet.com/searchResults?submitted=true&locale=en_EP&DB=EPODOC&ST=advanced&TI=&AB=&PN=&AP=&PR=&PD=&PA=skinbiotherapeutics&IN=&CPC=&IC=
How is the technology any different to a product like this if we don't know what these proprietary bacterial strains are?
https://www.amazon.co.uk/Natures-Aid-Pro-Derma-Bacteria-Chromium/dp/B078W7Z8ZV/ref=sr_1_6?dchild=1&keywords=psoriasis+supplement&qid=1622235936&rdc=1&sr=8-6
You seem like you'd be kicking yourself pretty hard in a few years if you saw this whole meat revolution coming and didn't take any position. If it genuinely worries you then a small position you can just forget about for a few years is surely the answer?
I see. Thanks for the correction. Do you have any idea what the 6 live probiotics are?
Thanks for your responses on the IP. I now see that bacteria can be patented. Regardless, with a bit of further research I see that the product doesn't actually contain any live bacteria so it was a moot point.
I can see in a presentation that the technology is based on 'probiotic bacterial lysates'. I inserted the definition of bacterial lysates below:
'Bacterial lysate medicines are made from bacterial cells that are broken down and are intended to stimulate the immune system to recognise and fight infections.'
So these are essentially bacteria which are broken down under either chemical or mechanical means and create an immune response.
In a presentation which I've found on their site (https://www.skinbiotherapeutics.com/stuart-ashman-presenting-at-the-share-profits-virtual-show-on-saturday-9th-may-2020/) they indicate that Lactobacillus rhamnoses was chosen to be converted into a lysate for multiple benefits: positive influence on the gut barrier, closes wounds and prevents pathogens. In the presentation, the CEO indicates these benefits apply equally to the skin and gut.
The CEO also indicates that their IP 'essentially' is the extraction of this bacteria and conversion to a lysate.
Interesting stuff, I'll have to do more research before deciding whether or not to invest.